![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1333976
¼¼°èÀÇ Àü»ç¸· ½ÃÀå : ÇöȲ ºÐ¼® ¹× ¿¹Ãø(2022-2030³â)Transfer Membrane Market: Current Analysis and Forecast (2022-2030) |
Àü»ç¸·(Æ®·£½ºÆÛ ¸âºê·¹ÀÎ, Transfer Membrane) ½ÃÀåÀº 2022-2030³â±îÁö ¾à 5%ÀÇ CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. Àü»ç¸· ½ÃÀåÀº Àü»ç¸·ÀÇ »ý»ê, À¯Åë ¹× ÆÇ¸Å¿Í °ü·ÃµÈ ¼¼°è »ê¾÷À» ¸»ÇÕ´Ï´Ù. ºí·ÔÆÃ ¸·À¸·Îµµ ¾Ë·ÁÁø Àü»ç¸·Àº ¿þ½ºÅÏ ºí·ÔÆÃ, ¼´ø ºí·ÔÆÃ, ³ë´ø ºí·ÔÆÃ µî ´Ù¾çÇÑ »ý¹°ÇÐÀû ºÐ¼® ±â¼ú¿¡ »ç¿ëµÇ´Â Ư¼ö ´Ù°ø¼º Àç·áÀÔ´Ï´Ù. Àü»ç¸·Àº ´Ü¹éÁú, DNA, RNA¿Í °°Àº »ý¹°ÇÐÀû ºÐÀÚ¸¦ °Ö ¸ÅÆ®¸¯½º¿¡¼ °íü ÁöÁöü(ÀϹÝÀûÀ¸·Î ¸· Ç¥¸é)·Î À̵¿½ÃŰ´Â °ÍÀ» ÃËÁøÇϵµ·Ï ¼³°èµÇ¾ú½À´Ï´Ù. ºÐÀÚ »ý¹°ÇÐ ¿¬±¸, »ý¸í °øÇÐ, ÀÓ»ó Áø´Ü¿¡ ÀϹÝÀûÀ¸·Î »ç¿ëµË´Ï´Ù. Àü»ç¸·ÀÇ ¼ö¿ä°¡ ´Ã¾î³ª°í ÀÖ´Â °ÍÀº Àü ¼¼°è¿¡¼ °¨¿°ÁõÀ̳ª À¯Àüº´ÀÌ ¸¸¿¬Çϰí Àֱ⠶§¹®ÀÔ´Ï´Ù. ¿¹¸¦ µé¾î HIV.gov¿¡ µû¸£¸é 2021³â¿¡´Â ¼¼°è¿¡¼ ÃßÁ¤µÈ 150¸¸ ¸íÀÌ HIV¿¡ °¨¿°µÇ¾úÀ¸¸ç, °°Àº ÇØ ¾à 3,840¸¸ ¸íÀÌ HIV¸¦ ¾Î°í ÀÖ¾ú½À´Ï´Ù. ÀÌ·¯ÇÑ ÇöÀúÇÑ Åë°è´Â Àü ¼¼°è À¯Àü¼º ÁúȯÀÌ Áõ°¡Çϰí ÀÖÀ¸¸ç ÇâÈÄ ½ÃÀå ¼ºÀå¿¡µµ ±â¿©ÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ¶ÇÇÑ Çмú±â°ü, ¿¬±¸±â°ü, »ê¾÷¿¬±¸¼Ò¿¡¼ R&D Ȱµ¿¿¡ ´ëÇÑ ÅõÀÚ°¡ Áõ°¡ÇÔ¿¡ µû¶ó Àü»ç¸· ½ÃÀåÀÌ ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ, ´Ü¹éÁú°ú À¯ÀüÀÚÀÇ ±¸Á¶¿Í ±â´ÉÀ» ÀÌÇØÇÏ´Â °Í¿¡ ´ëÇÑ ÁÖ¸ñÀÌ ³ô¾ÆÁü¿¡ µû¶ó ¿þ½ºÅÏ ºí·ÔÆÃ, ¼´ø ºí·ÔÆÃ, ³ë´ø ºí·ÔÆÃ µî ±â¼ú¿¡¼ Àü»ç¸·ÀÇ ¼ö¿ä°¡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ±×·¯³ª Àü»ç¸·ÀÇ °íºñ¿ë, ¸· ¸·Èû, Àç»ç¿ë¼º Á¦ÇÑ µî ½ÃÀå ¾ïÁ¦ ¿äÀÎ Áß ÀϺδ Àü ¼¼°è¿¡¼ ÀÌ ½ÃÀå ¼ºÀåÀ» ¹æÇØÇϰí ÀÖ½À´Ï´Ù.
Á¦Ç°¿¡ µû¶ó ½ÃÀåÀº PVDF, ´ÏÆ®·Î ¼¿·ê·Î¿À½º, ³ªÀÏ·ÐÀ¸·Î ±¸ºÐµË´Ï´Ù. ±× Áß¿¡¼µµ PVDF ºÎ¹®ÀÌ 2021³â ½ÃÀå¿¡¼ Å« Á¡À¯À²À» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. PVDFÀÇ Àü»ç¸·Àº ´Ü¹éÁúÀÇ ½ºÆ®¸®ÇÎ ¹× ÀçÇÁ·ÎºùÀ» ¿ëÀÌÇÏ°Ô ÇÏ´Â ¹Ý¸é, ´Ù¸¥ À¯ÇüÀÇ ¸âºê·¹ÀÎÀ» ´ëüÇÏ´Â ¸Å¿ì ³»±¸¼ºÀÌ ÀÖ´Â ÈÇÐÀûÀ¸·Î ºÒȰ¼ºÀÎ ¸âºê·¹ÀÎÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ¸âºê·¹ÀÎÀº ¼Ò¼ö¼ºÀ̱⠶§¹®¿¡ ´Ü¹éÁú°ú °ÇÑ Á¢ÃËÀ» Çü¼ºÇÒ ¼ö ÀÖÀ¸¸ç, ´õ ³ªÀº ´Ü¹éÁú °áÇÕ°ú È¿À²ÀûÀÎ ´Ü¹éÁú ¿î¼ÛÀÌ °¡´ÉÇÕ´Ï´Ù.
Àü»ç¸¦ ¹ÙÅÁÀ¸·Î ½ÃÀåÀº ½À½Ä ¶Ç´Â ÅÊÅ© Àü»ç, ¼¼¹Ì µå¶óÀÌ ÀÏ·ºÆ®·Î ºí·ÔÆÃ(¼¼¹Ì µå¶óÀÌ Àü»ç), °Ç½Ä ÀÏ·ºÆ®·Î ºí ·ÎÆÃ(µå¶óÀÌ Àü»ç) µîÀ¸·Î À̺е˴ϴÙ. ±× Áß¿¡¼µµ µå¶óÀÌ ÀÏ·ºÆ®·Î ºí·ÔÆÃ ºÎ¹®Àº »ç¿ëÀÚ Ä£ÈÀûÀÌ°í Æí¸®ÇÑ ÀÛµ¿ ¹æ¹ý°ú Á¶±â Àü»ç ¼Óµµ¿Í °°Àº ÀåÁ¡À¸·Î ÀÎÇØ ½ÃÀå¿¡¼ ´õ ³ôÀº CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ, ÀÌ Á¢±Ù¹ýÀº °ÖÀ» ¿ÏÃæ¾×À¸·Î ÆòÇüÈÇÒ Çʿ䰡 ¾ø±â ¶§¹®¿¡ Àü»ç ¿Ï·á±îÁö ¼Ò¿ä ½Ã°£À» ´ÜÃà½Ãŵ´Ï´Ù.
¿ëµµ¿¡ µû¶ó ½ÃÀåÀº ¿þ½ºÅÏ ºí¶ùÆÃ, ¼´ø ºí¶ùÆÃ, ³ë´ø ºí¶ùÆÃ µîÀ¸·Î ³ª´¹´Ï´Ù. ±× Áß¿¡¼µµ ¿þ½ºÅÏ ºí·ÔÆÃ ºÐ¾ß´Â ½ÃÀå¿¡¼ ´õ ³ôÀº CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµÇ°í ÀÖ½À´Ï´Ù. ÀÌ´Â ÀÌ ±â¼úÀÌ Áø´Ü ¹× ÀÓ»ó °Ë»ç¿¡ ³Î¸® »ç¿ëµÇ±â ¶§¹®ÀÔ´Ï´Ù. ¿þ½ºÅÏ ºí·ÔÆÃÀº °í°¨µµ¿Í ƯÀ̼º°ú °°Àº ´Ü¹éÁú °ËÃâÀÇ ÀÌÁ¡À» °¡Áö°í ÀÖÀ¸¸ç ºÐ¼® Åø·Î »ç¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù.
ÃÖÁ¾ »ç¿ëÀÚº°·Î´Â ¹ÙÀÌ¿ÀÁ¦¾à¡¤Á¦¾àȸ»ç, Çмú¡¤¿¬±¸±â°ü, Áø´Ü½Ç·Î ºÐ·ùµË´Ï´Ù. ÀÌ Áß ¹ÙÀÌ¿ÀÀǾàǰ¡¤Á¦¾à±â¾÷ Ä«Å×°í¸®´Â »ó´çÇÑ ½ÃÀå Á¡À¯À²À» ȹµæÇϰí ÀÖÀ¸¸ç ¿¹Ãø±â°£ Áß Å« CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÅõÀÚ´Â Àü»ç¸·°ú °°Àº ºÐÀÚ »ý¹°ÇÐÀû Á¢±Ù¹ýÀÇ »ç¿ëÀ» Áõ°¡½ÃŰ°í ½ÃÀå¿¡ ÀÌÀÍÀ» °¡Á®¿Ã °ÍÀ¸·Î »ý°¢µË´Ï´Ù.
Àü»ç¸·ÀÇ ½ÃÀå µµÀÔ¿¡ ´ëÇÑ ÀÌÇØ¸¦ ³ôÀ̱â À§ÇØ ½ÃÀåÀº ºÏ¹Ì(¹Ì±¹, ij³ª´Ù, ±âŸ ºÏ¹Ì Áö¿ª), À¯·´(µ¶ÀÏ, ÇÁ¶û½º, ÀÌÅ»¸®¾Æ, ½ºÆäÀÎ, ¿µ±¹, ±âŸ À¯·´ Áö¿ª), ¾Æ½Ã¾Æ ÅÂÆò¾ç(Áß±¹, ÀϺ», Àεµ , ±âŸ APAC ±¹°¡), ¼¼°èÀÇ ±âŸ Áö¿ª¿¡¼ ¼¼°èÀÇ Á¸À縦 ±â¹ÝÀ¸·Î ºÐ¼®µË´Ï´Ù. ºÏ¹Ì, ƯÈ÷ ¹Ì±¹Àº »ý¸í °øÇаú Á¦¾à ¿¬±¸ÀÇ Áß½ÉÁöÀÔ´Ï´Ù. ÀÌ Áö¿ªÀº ´Ü¹éÁúüÇÐ, À¯ÀüüÇÐ, °³ÀÎÈ ÀÇ·á, ÀǾàǰ µî ºÐ¾ß¿¡¼ ÇöÀúÇÑ Áøº¸¸¦ ÀÌ·ç°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¹ßÀüÀ¸·Î ÀÎÇØ ´Ù¾çÇÑ ¿¬±¸ ¹× Áø´Ü ¿ëµµ¿¡ ÇʼöÀûÀÎ Åø·Î Àü»ç¸·¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ºÏ¹Ì¿¡¼´Â Á¤ºÎ, ¹Î°£´Üü, ÇмúÁ¶»ç±â°üÀÌ »ý¸í°úÇÐ ¿¬±¸¿¡ ¸¹Àº ÀÚ±ÝÀ» ÇÒ´çÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÀÚ±Ý Áö¿øÀº ´Ü¹éÁú ºÐ¼®, ÇÙ»ê ¿¬±¸, ¹ÙÀÌ¿À¸¶Ä¿ Ž»ö µî Àü»ç¸·À» ÀÌ¿ëÇÑ ¿¬±¸ ÇÁ·ÎÁ§Æ®¸¦ Áö¿øÇÕ´Ï´Ù. È®¸³µÈ ¿¬±¸ ÀÎÇÁ¶óÀÇ Á¸Àç¿Í »ý¸í°úÇÐ ºÐ¾ß¿¡ ´ëÇÑ Á¤ºÎ ÅõÀÚ Áõ°¡´Â ºÏ¹Ì Áö¿ª¿¡¼ Àü»ç¸·ÀÇ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î ¹Ì±¹ º¸°Çº¹ÁöºÎ´Â 2022³â 9¿ù ¹Ì±¹ÀÇ »ý¸í°øÇÐ ¿¬±¸ ¹× Á¦Á¶ È®´ë¸¦ À§ÇØ ±¹°¡ »ý¸í°øÇÐ ¹× »ý¸í°øÇÐ ±¸»óÀÇ ÀÏȯÀ¸·Î 4,000¸¸ ´Þ·¯ ÀÌ»óÀÇ ÅõÀÚ¸¦ ¹ßÇ¥Çß½À´Ï´Ù.
Thermofisher Scientific, Danaher, Bio-Rad Laboratories, Merck KGaA, Parkin Elmer, Abcum, Santa Cruz Biotechnology, ATTO, Azul Biosystems, Advanced µî ÁÖ¿ä ±â¾÷ÀÔ´Ï´Ù. ÀϺΠM&A¿Í Á¦ÈÞµµ ÀÌ·ç¾îÁö°í ÀÖ½À´Ï´Ù.
The transfer membrane market is expected to register a CAGR of approx. 5% over the period of 2022-2030. The transfer membrane market refers to the global industry involved in the production, distribution, and sale of transfer membranes. Transfer membranes, also known as blotting membranes, are specialized porous materials used in various biological and analytical techniques, such as Western blotting, Southern blotting, and Northern blotting. Transfer membranes are designed to facilitate the transfer of biological molecules, such as proteins, DNA, and RNA, from a gel matrix onto a solid support, typically a membrane surface. They are commonly used in molecular biology research, biotechnology, and clinical diagnostics. The growing demand for transfer membranes can be attributed to the high prevalence of infectious and genetic diseases around the globe. For instance, according to HIV.gov, an estimated 1.5 million individuals worldwide acquired HIV infection in 2021, while around 38.4 million individuals were suffering from the disease in the same year. Owing to the glaring statistics growth of genetic disease across the globe would contribute to the growth of the market in the forthcoming period as well. Furthermore, the transfer membrane market is anticipated to grow on account of the increasing investment in research and development activities across academic institutions, research organizations, and industrial laboratories. Moreover, the increasing focus on understanding the structure and function of proteins and genes has led to a growing demand for transfer membranes in techniques such as western blotting, southern blotting, and northern blotting. However, some of the restraints in the market including the high cost of transfer membranes and membrane clogging and limited reusability are impeding the growth of this market all over the world.
Based on product, the market is segmented into PVDF, nitrocellulose, and nylon. Among them, the PVDF segment captured a significant share of the market in 2021. PVDF transfer membranes make easier protein stripping and re-probing possible while providing an extremely durable and chemically inert alternative to other kinds of membranes. Because these membranes are hydrophobic, they can form strong contacts with proteins, allowing for better protein binding and efficient protein transport.
Based on the transfer, the market is bifurcated into wet or tank transfer, semi-dry electroblotting (semi-dry transfer), dry electroblotting (dry transfer), and others. Among them, the dry electroblotting segment is expected to grow at a higher CAGR in the market owing to the benefits, such as its user-friendly and convenient manner of operation as well as early transfer speed. Furthermore, the approach eliminates the requirement to equilibrate gels in a buffer, lowering the time required to complete the transfer.
Based on the application, the market is bifurcated into western blotting, southern blotting, northern blotting, and others. Among them, the western blotting segment is expected to grow at a higher CAGR in the market. This can be ascribed to the technique's widespread use in diagnostic and clinical testing activities. Western blotting has advantages for protein detection such as high sensitivity and specificity, allowing it to be used as an analytical tool.
Based on the end-user, the transfer membrane market has been classified into biopharmaceutical & pharmaceutical companies, academic & research institutes, and diagnostic labs. Among them, the into biopharmaceutical & pharmaceutical companies category grabbed a considerable market share, and it is expected to grow at a significant CAGR during the forecast period. the increased research and development operations conducted by such corporations for the discovery of innovative medicines and vaccines. Such investments are likely to increase the use of molecular biology techniques such as transfer membranes, which will benefit the market.
For a better understanding of the market adoption of transfer membrane, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, and Rest of North America), Europe (Germany, France, Italy, Spain, U.K., and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of APAC), and Rest of World. North America, particularly the United States, is a hub for biotechnology and pharmaceutical research. The region is witnessing significant advancements in areas such as proteomics, genomics, personalized medicine, and drug discovery. These advancements drive the demand for transfer membranes as essential tools in various research and diagnostic applications. Moreover, governments, private organizations, and academic institutions in North America allocate substantial funding for life sciences research. The availability of funding supports research projects that rely on transfer membranes for protein analysis, nucleic acid studies, and biomarker discovery. This financial support contributes to the growth of the transfer membrane market in the region. the presence of well-established research infrastructure and rising government investments in the life sciences domain drive the demand for transfer membranes in the North America region. For instance, in September 2022, the U.S. Department of Health and Human Services declared an investment of above USD 40.0 million as a part of the National Biotechnology and Bio-manufacturing initiative for the expansion of biotechnology research and manufacturing in the country.
Some of the major players operating in Thermo Fisher Scientific, Inc.; Danaher; Bio-Rad Laboratories; Merck KGaA; PerkinElmer, Inc.; Abcam Plc.; Santa Cruz Biotechnology, Inc.; ATTO Corporation; Azure Bio systems Inc.; Advansta Inc among others. Several M&A's along with partnerships have been undertaken.
13 TRANSFER MEMBRANE MARKET OPPORTUNITIES